Christopher Geven

995 total citations
11 papers, 516 citations indexed

About

Christopher Geven is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Molecular Biology. According to data from OpenAlex, Christopher Geven has authored 11 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Christopher Geven's work include Neuropeptides and Animal Physiology (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Receptor Mechanisms and Signaling (5 papers). Christopher Geven is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Sepsis Diagnosis and Treatment (8 papers) and Receptor Mechanisms and Signaling (5 papers). Christopher Geven collaborates with scholars based in Netherlands, France and Germany. Christopher Geven's co-authors include Peter Pickkers, Matthijs Kox, Andreas Bergmann, Alexandre Mebazaa, Joachim Struck, Dirk van Lier, Guus P. Leijte, Jozine M. ter Maaten, Daan Kremer and Marco Metra and has published in prestigious journals such as Critical Care Medicine, Frontiers in Immunology and Toxicology and Applied Pharmacology.

In The Last Decade

Christopher Geven

11 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Geven Netherlands	10	181	174	158	113	101	11	516
Naofumi Doi Japan	11	242 1.3×	120 0.7×	258 1.6×	213 1.9×	48 0.5×	26	675
Takashi Nagura Japan	11	171 0.9×	144 0.8×	151 1.0×	144 1.3×	45 0.4×	12	548
Hans‐Dirk Düngen Germany	14	41 0.2×	65 0.4×	301 1.9×	104 0.9×	41 0.4×	22	546
Michael Resl Austria	15	43 0.2×	79 0.5×	462 2.9×	103 0.9×	108 1.1×	53	885
P. W. Eichenholz United States	4	22 0.1×	193 1.1×	146 0.9×	126 1.1×	164 1.6×	6	541
Emerson Te United States	15	38 0.2×	134 0.8×	77 0.5×	90 0.8×	114 1.1×	35	548
Xiangshao Fang China	15	24 0.1×	102 0.6×	61 0.4×	178 1.6×	36 0.4×	32	494
Hongwei Cai China	12	35 0.2×	111 0.6×	54 0.3×	243 2.2×	28 0.3×	22	581
Linda Dee United States	5	23 0.1×	322 1.9×	333 2.1×	196 1.7×	185 1.8×	9	877

Countries citing papers authored by Christopher Geven

Since Specialization

Citations

This map shows the geographic impact of Christopher Geven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Geven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Geven more than expected).

Fields of papers citing papers by Christopher Geven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Geven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Geven. The network helps show where Christopher Geven may publish in the future.

Co-authorship network of co-authors of Christopher Geven

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Geven. A scholar is included among the top collaborators of Christopher Geven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Geven. Christopher Geven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Blet, Alice, Benjamin Deniau, Christopher Geven, et al.. (2019). Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats. Intensive Care Medicine Experimental. 7(1). 25–25. 23 indexed citations

Geven, Christopher, Alice Blet, Matthijs Kox, et al.. (2019). A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2). BMJ Open. 9(2). e024475–e024475. 28 indexed citations

Blet, Alice, Christopher Geven, Benjamin Deniau, et al.. (2019). Bioactive Adrenomedullin, Organ Support Therapies, and Survival in the Critically Ill: Results from the French and European Outcome Registry in ICU Study. Critical Care Medicine. 48(1). 49–55. 14 indexed citations

Geven, Christopher, Matthijs Kox, Alice Blet, et al.. (2019). Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates. Toxicology and Applied Pharmacology. 369. 1–16. 4 indexed citations

Lier, Dirk van, Christopher Geven, Guus P. Leijte, & Peter Pickkers. (2018). Experimental human endotoxemia as a model of systemic inflammation. Biochimie. 159. 99–106. 63 indexed citations

Geven, Christopher, Dirk van Lier, Alice Blet, et al.. (2018). Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in healthy subjects. British Journal of Clinical Pharmacology. 84(9). 2129–2141. 37 indexed citations

Voors, Adriaan A., Daan Kremer, Christopher Geven, et al.. (2018). Adrenomedullin in Heart Failure: Pathophysiology and Therapeutic Application. European Journal of Heart Failure. 21(2). 163–171. 153 indexed citations

Geven, Christopher, Matthijs Kox, & Peter Pickkers. (2018). Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis. Frontiers in Immunology. 9. 292–292. 89 indexed citations

Geven, Christopher, Andreas Bergmann, Matthijs Kox, & Peter Pickkers. (2018). Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis. Shock. 50(2). 132–140. 53 indexed citations

10.

Geven, Christopher, Esther Peters, Joachim Struck, et al.. (2018). Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis. Shock. 50(6). 648–654. 41 indexed citations

11.

Baal, Mark C. van, Christopher Geven, Gerjon Hannink, et al.. (2014). Association between probiotics and enteral nutrition in an experimental acute pancreatitis model in rats. Pancreatology. 14(6). 470–477. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact